DNA Nanoclusters Combined with One‐Shot Radiotherapy Augment Cancer Immunotherapy Efficiency
Authors:
- 15 March 2023
- journal article
- research article
- Published by Wiley in Advanced Materials
- Vol. 35 (17) , e2208546
Abstract
Immunotherapy shows immense promise for improving cancer treatment. Combining immunotherapy with radiotherapy provides a conspicuous advantage due to its enhanced abscopal effect. However, established immune tolerance mechanisms in the tumor microenvironment can hamper the generation of a sufficient abscopal effect. Herein, a type of DNA nanocluster (DNAnc) that is self‐assembled by a CpG‐ODNs‐loaded Y‐shaped double‐stranded DNA vector based on the unique complementary base‐pairing rules is designed. The unique structure of DNAnc makes it load more than ≈8125.5 ± 822.5 copies of CpG ODNs within one single nanostructure, which effectively increases resistance to nuclease degradation and elevates the efficiency of repolarizing macrophages to an M1‐like phenotype. Mechanistic studies reveal that more DNAncs are endocytosed by macrophages in the cancer tissue and repolarized macrophages to elicit a robust abscopal effect with the accumulation of macrophages induced by radiotherapy, generating potent, long‐term, and durable antitumor immunity for the inhibition of tumor metastasis and the prevention of tumor recurrence, which provides a novel strategy to boost cancer immunotherapy.Keywords
Funding Information
- National Natural Science Foundation of China (82172661, 81771968, 81773222, 31400719)
This publication has 48 references indexed in Scilit:
- A Triggered DNA Hydrogel Cover to Envelop and Release Single CellsAdvanced Materials, 2013
- DNAsomes: Multifunctional DNA‐Based NanocarriersSmall, 2010
- Photocrosslinked DNA Nanospheres for Drug DeliveryMacromolecular Rapid Communications, 2010
- Fluorescence Logic‐Signal‐Based Multiplex Detection of Nucleases with the Assembly of a Cationic Conjugated Polymer and Branched DNAAngewandte Chemie International Edition, 2009
- A cell-free protein-producing gelNature Materials, 2009
- Randomized Phase II Trial of a Toll-Like Receptor 9 Agonist Oligodeoxynucleotide, PF-3512676, in Combination With First-Line Taxane Plus Platinum Chemotherapy for Advanced-Stage Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2008
- Multiplexed detection of pathogen DNA with DNA-based fluorescence nanobarcodesNature Biotechnology, 2005
- Immunotherapeutic uses of CpG oligodeoxynucleotidesNature Reviews Immunology, 2004
- CpG Motifs in Bacterial DNA and Their Immune EffectsAnnual Review of Immunology, 2002
- Palliative irradiation of bone metastasesCancer Treatment Reviews, 1989